Association Between Multiple Myeloma With VTE and Increased Mortality at 2, 5 Years
A study presented at the 2018 ASCO Annual Meeting investigated the mortality risk for patients with multiple myeloma who develop VTE.
ASCO 2018
Intervention With Lay Health Workers Has Positive Effect on Cancer Patients’ Experience
An intervention utilizing lay health workers supervised by NPs lowered health care costs and improved patient satisfaction.
Head and Neck Cancer Survival Improved When irAEs Occur During Anti-PD-1 Therapy
Researchers evaluated whether the development of irAEsc among patients with metastatic head and neck cancer who have failed platinum-based chemotherapy could improve patient outcomes.
Ado-trastuzumab Emtansine Effective in HER2 Amplified Non-breast, Non-gastric Cancers
Study results presented at 2018 ASCO Annual Meeting demonstrated effectiveness of ado-trastuzumab emtansine in non-breast non-gastric HER2-amplified cancers.
Dexrazoxane May Reduce Cardiotoxicity in Pediatric AML
Children’s Oncology Group study reported on the effect of dexrazoxane on cardiotoxicity of anthracycline-containing regimens in pediatric patients with AML at the 2018 ASCO Annual Meeting.
Walking Program Improved Physical Function, But Not Fatigue, After RT for Breast Cancer
In a multicenter phase 2 study, the Walk With Ease program was evaluated for its effectiveness in reducing radiotherapy-associated fatigue vs usual care in older patients with breast cancer. Results were presented at 2018 ASCO Annual Meeting.
Overall Survival Benefit With Prostate Cancer Vaccine Not Duplicated in Phase 3 Trial
Latest findings do not confirm an overall survival (OS) benefit found in a previous randomized phase 2 trial.
Mindfulness Training May Improve End-of-Life Conversations in Advanced Cancer
Study presented at 2018 ASCO Annual Meeting determined the feasibility of using a mindfulness intervention to improve quality of life and confidence in advance care planning discussions among patient-family caregiver dyads.
Palliative Issues Inadequately Addressed Among Hospitalized Cancer Patients
Consultations for palliative care for hospitalized highly symptomatic patients with cancer is low regardless of curability or whether patient has hematologic or solid cancer, a study presented at 2018 ASCO has shown.
Dose-Dense Chemotherapy for Breast Cancer May Impair Lung Function
Long-term analysis determined the effect of postadjuvant dose-dense chemotherapy on DLCO among women with breast cancer.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in ASCO 2018
Loading... 
Loading...